When Should I Take Losartan: Morning or Night?

For most people with high blood pressure, taking losartan in the morning or at night makes no meaningful difference in cardiovascular outcomes. The largest and most rigorous clinical trials have found that the timing of antihypertensive medications, losartan included, does not change the risk of heart attack, stroke, or death. That said, specific situations can tip the balance toward one time of day, and a few years of conflicting studies have left a lot of confusion worth sorting through.

What the Largest Trials Actually Found

The question of morning versus evening dosing was put to the test in the TIME study, a large UK trial involving over 21,000 adults with hypertension. Participants were randomly assigned to take their usual blood pressure medications either in the morning or at bedtime, then followed for several years. The result was clear: major cardiovascular events occurred at nearly identical rates in both groups. About 3.4% of the evening group and 3.7% of the morning group experienced a primary endpoint event, and the difference was not statistically significant. The finding held across every prespecified subgroup the researchers examined.¹

A 2025 systematic review and meta-analysis pooling five randomized controlled trials with over 46,000 patients reinforced this conclusion. When the authors restricted their analysis to the three trials at low risk of bias, evening dosing showed no reduction in major cardiovascular events compared with morning dosing.² The practical takeaway from these studies is that you can take your medication at whatever time helps you remember it and minimizes side effects.

Why You May Have Heard the Opposite

If you’ve come across advice that bedtime dosing dramatically reduces heart attacks and strokes, that likely traces back to two earlier trials, MAPEC and Hygia, both led by the same Spanish research group. These studies reported eye-catching results: roughly a 50-60% reduction in cardiovascular events and mortality with bedtime dosing. Those numbers drew attention worldwide and influenced some clinical guidelines.

The problem is that independent experts found serious issues with both trials. The Hygia trial, published in the European Heart Journal, drew a formal Expression of Concern from the journal’s editors.³ Critics pointed out that the enormous benefits reported were biologically implausible given the tiny blood pressure differences observed between groups. In Hygia, the average 24-hour blood pressure difference between the bedtime and morning groups was only about 1.6/1.2 mmHg, yet the trial claimed a 50% reduction in cardiovascular events. MAPEC showed a similarly outsized benefit from an even smaller pressure difference. Both trials also had suspiciously low dropout rates, which researchers flagged as unusual for trials of that size and duration.⁴

When the TIME study and subsequent well-designed trials failed to replicate those dramatic results, the consensus shifted. Bedtime dosing is not harmful, but the evidence that it provides a special cardiovascular advantage over morning dosing is weak at best and may have been based on flawed data.

How Losartan Moves Through Your Body

After you swallow a losartan tablet, it absorbs quickly and reaches peak blood levels within one to two hours. Your liver then converts about 14% of the dose into an active metabolite called E-3174, which is far more potent than losartan itself and sticks around longer, with a half-life of roughly six to nine hours.⁵ That relatively short duration means that by the end of a 24-hour dosing interval, blood pressure coverage can start to thin out. Whether that tail end falls during your sleeping hours or your waking hours depends on when you take the pill.

This pharmacokinetic profile is part of why some researchers have explored twice-daily dosing for losartan rather than simply shifting the single dose from morning to night. A real-world effectiveness study found that splitting losartan into two daily doses gave patients slightly higher odds of reaching a systolic blood pressure below 130 mmHg compared to once-daily dosing, though most of the differences became nonsignificant after adjusting for other factors.⁶ Another study comparing twice-daily to once-daily evening losartan suggested that twice-daily dosing was more effective at eliminating the nondipping pattern, where blood pressure fails to drop adequately at night.⁷ This is worth discussing with your doctor if your blood pressure seems well controlled during the day but not at night.

The Morning Blood Pressure Surge

Blood pressure is not constant throughout the day. It normally drops during sleep, then rises sharply in the early morning hours as you wake up and become active. This morning surge is clinically significant because heart attacks, strokes, dangerous heart rhythms, and sudden cardiac death all peak between roughly 6 AM and noon.⁸ The rapid rise in pressure can promote the rupture of vulnerable arterial plaques. Research has found that a steeper rate of morning systolic blood pressure increase independently predicts both heart attacks and strokes.⁹

If your morning blood pressure runs high despite treatment, your doctor may have you take losartan in the morning so the drug’s peak activity coincides with the vulnerable window. Alternatively, a combination of losartan with a low-dose diuretic (hydrochlorothiazide) has shown particular effectiveness at taming morning hypertension. In one study, a losartan/hydrochlorothiazide combination controlled isolated morning hypertension in over 80% of patients, compared with about 21% on high-dose losartan alone.¹⁰ That finding is less about timing and more about drug selection, but it highlights that the pattern of your blood pressure throughout the day matters as much as the average number.

When Nighttime Dosing Might Help

Although the big outcome trials show no general advantage to bedtime dosing, there are specific clinical scenarios where it makes physiological sense to shift medication to the evening. The most studied is chronic kidney disease. A meta-analysis of trials in hypertensive patients with kidney disease found that evening dosing reduced nondipping blood pressure patterns by about 40% and lowered nighttime systolic blood pressure by roughly 3 mmHg more than morning dosing.¹¹ Whether that translates to fewer cardiovascular events in this population remains an open question, but the blood pressure pattern itself is a recognized risk factor: nondipping is associated with worse kidney and heart outcomes independent of average 24-hour pressure.¹²

Another group that may benefit from bedtime dosing includes people with type 2 diabetes, who often have abnormal nighttime blood pressure patterns. A crossover trial testing an ARB (olmesartan, in the same drug class as losartan) in diabetic patients found that bedtime dosing significantly lowered nighttime blood pressure and increased the percentage of patients with a healthy dipping pattern, compared to morning dosing of the same drug.¹³ That study used a different ARB, but the mechanism is shared across the class, and a study comparing losartan with telmisartan confirmed that both lower nighttime blood pressure in patients with diabetic kidney disease.¹⁴

If your doctor has ordered ambulatory blood pressure monitoring (a device you wear for 24 hours that takes periodic readings), the results can reveal whether you are a dipper, nondipper, or extreme dipper. That information is one of the best tools for personalizing dosing time. Guidelines in some countries have recommended nocturnal blood pressure control as an important part of high-quality hypertension management, and ambulatory monitoring is the only way to measure it reliably.¹⁵

Risks of Bedtime Dosing in Vulnerable Groups

Shifting blood pressure medications to bedtime is not without trade-offs, and for some people the risks genuinely outweigh any theoretical benefit. An excessive drop in nighttime blood pressure, sometimes called “extreme dipping,” has been linked to cardiovascular events, a specific type of vision loss called normal-tension glaucoma, cognitive decline, and increased fall risk in older adults.¹⁶ The concern is particularly acute for frail elderly people who may already have low nighttime blood pressure and are at high risk for falls.

A randomized trial specifically designed to test bedtime dosing in frail older adults living in nursing homes found that switching blood pressure medications to bedtime did not increase death, stroke, heart failure, falls, fractures, pressure ulcers, or cognitive decline compared with continuing morning dosing.¹⁷ That is reassuring, but it also means bedtime dosing provided no advantage in this group either. For older adults who already feel lightheaded at night or who have a history of falls, there is no compelling reason to introduce a new risk by moving medications to bedtime, even a small one.

Shift Workers and Disrupted Sleep Schedules

Advice about “morning” versus “nighttime” dosing assumes you sleep at night and are awake during the day. That is not the reality for shift workers, people with irregular schedules, or those with sleep disorders. Circadian misalignment, where your internal clock is out of sync with your actual sleep-wake cycle, has its own effects on blood pressure regulation and cardiovascular risk.¹⁸

If you work nights and sleep during the day, the standard framing of “take it at bedtime to lower nighttime pressure” falls apart, because your body’s daytime is everyone else’s nighttime. In that case, timing losartan relative to your own sleep period rather than by the clock is more physiologically coherent. No major trial has specifically tested blood pressure medication timing in rotating-shift workers, so the best approach is to work with your doctor and, if possible, get ambulatory monitoring that captures your actual daily rhythm.

Losartan and Sleep

One practical worry about taking any medication at bedtime is whether it could disrupt sleep. Some blood pressure drugs, particularly certain beta-blockers, are known to interfere with melatonin production and cause sleep disturbances. Losartan does not appear to share that problem. A study measuring melatonin levels in people taking losartan for a week found no significant change in the circadian rhythm of melatonin secretion compared to baseline.¹⁹ So if you do choose to take losartan at night, it is unlikely to keep you awake or worsen your sleep quality through that pathway.

The most commonly reported side effects of losartan, such as dizziness and fatigue, could theoretically be less bothersome at bedtime since you would sleep through the period of peak drug levels. Conversely, if losartan makes you need to urinate more often (it can, through its effects on aldosterone and sodium handling), a bedtime dose could mean more nighttime trips to the bathroom. These are individual trade-offs worth paying attention to during the first few weeks after changing your dosing time.

When Combination Therapy Changes the Calculus

Many people with hypertension take losartan alongside other blood pressure medications. A systematic review of trials testing two-drug combinations found that in nearly all cases, taking the combination at bedtime rather than in the morning produced better nighttime blood pressure control without causing dangerously low blood pressure during sleep.²⁰ However, a large meta-analysis of 107 trials examining evening versus morning dosing of various drug classes, including ARBs like losartan, found that the positive signals for evening dosing were heavily driven by data from the same research groups whose work has drawn methodological criticism.²¹ Adherence and side-effect profiles were similar regardless of timing in most analyses.

If you take losartan in combination with a diuretic like hydrochlorothiazide, morning dosing is often preferred simply because the diuretic will increase urine output. Taking a diuretic at bedtime usually means interrupted sleep, which can hurt adherence and overall well-being. In that case, the practical consideration of sleep quality overrides any marginal blood pressure benefit from nighttime dosing.

How to Decide

Given the evidence, your decision about when to take losartan should be guided by your own circumstances rather than a one-size-fits-all rule. A few questions worth considering with your doctor:

Do you have a nondipping pattern? If ambulatory monitoring has shown that your blood pressure does not drop adequately at night, bedtime dosing or split dosing may help normalize the pattern, particularly if you have kidney disease or diabetes.
Is your morning blood pressure elevated? If your readings spike on waking, a morning dose ensures peak drug activity during the highest-risk hours. Adding a low-dose diuretic may be more effective than changing the clock.
Are you taking a diuretic too? If losartan is combined with hydrochlorothiazide, morning dosing avoids the problem of nighttime bathroom visits.
Do you experience dizziness or fatigue from losartan? Moving the dose to bedtime lets you sleep through the peak side-effect window.
What time helps you remember? The biggest risk factor for poor blood pressure control is not taking the medication at all. A dose taken consistently at any time of day is better than a dose taken erratically at the “optimal” time.

If none of those considerations apply, the evidence says it genuinely does not matter. Take losartan at whichever time you are least likely to forget it.

Losartan Compared with Longer-Acting ARBs

Losartan’s active metabolite has a half-life of six to nine hours, making it one of the shorter-acting drugs in its class.⁵ Longer-acting ARBs like telmisartan, which has a half-life of about 24 hours, provide more even blood pressure coverage over the full dosing interval. In a head-to-head comparison in patients with diabetic kidney disease, telmisartan produced significantly greater improvements in nighttime blood pressure and 24-hour blood pressure variability than losartan.¹⁴ If nighttime blood pressure control is a primary goal and your doctor is choosing between ARBs, the drug itself may matter more than the time you take it. That does not mean losartan is a poor choice for most people with hypertension; it simply means that for patients whose 24-hour profiles show inadequate nighttime coverage, switching to a longer-acting ARB is an alternative to rearranging your dosing schedule.